We are an Italian multinational, established in 1946, with a vocation to create solutions to meet new challenges in health and improve quality of life for people.

We have understood the regenerating potential of hyaluronic acid since the 1950s and today we are one of the leading global players in the manufacture of hyaluronic acid-based products. Full control of the supply chain, from research to marketing, sets us apart and for this reason we define ourselves as a fully integrated company.

Regenerating the Natural Beauty
with Pure Science

We’re bringing our years of research and unique technologies to medical aesthetics in order to combine innovative protocols and applications involving proprietary hyaluronic acid-based products and autologous biological treatments. We offer both to practitioners and to patients, aesthetic solutions that preserve the person’s natural beauty and unique identity, consistent with scientific approach and guidelines of tissue engineering.

+ 0
Fidia's patents
+ 0
Years of research into the hyaluronic acid molecule
+ 0
Countries worldwide where our products are available

Research Hyaluronic
Acid in our

We study the effects of hyaluronic acid on the body and try to make it available where it is needed.

We produce pharmaceutical-grade hyaluronic acid, in a wide range of molecular weights and with peculiar chemical- physical characteristics, depending on the indications and the desired properties of finished product.

Today we have more than 1,300 international patents and our work has brought them to life in several therapeutic areas.

HOW We export our quality all over the world

We market our products in Italy and abroad. For this reason, Fidia is periodically inspected by national and international regulatory authorities (AIFA, the Italian Ministry of Health, US FDA, Korean Ministry of Food and Drug Safety [KFDA], ANVISA Brazil, Pharmaceutical Inspectorate of the Ministry of Industry and Trade of the Russian Federation, UkrMedCert, UCA) and Notified Bodies (GMED, ISS, TUV, IMQ, Certiquality, Eurofins Biolab).

The regenerative power of Hyaluronic Acid

The regenerative power of Hyaluronic Acid

Nearly all biological effects of hyaluronan observed in vitro and in vivo systems depend on its molecular weight and its concentration.

Fidia’s approach in developing the Hyal-System Line lies in the Weight – Concentration – Technology (WCT) Concept, that is the unique combination of these three variables exploit different structural and biological properties of HA, enabling each Hyal-System Line product to bring out different targeted benefits.


From the regenerating power of hyaluronic acid to the future of medicine

After decades of research into hyaluronic acid, which is known for its benefits in the natural repair and regeneration processes of damaged tissues, today we are also progressing in the field of regenerative medicine.

Regenerative medicine offers a promising synergistic role with hyaluronic acid, thanks to the development of new therapeutic strategies in the areas we work in. We have acquired and developed technologies to improve the availability of growth factors in tissues where there has been a loss in functionality as well as other systems associated with adipose tissue and its wide-ranging potential.



To access this page, please click YES if you are a healthcare professional.
If you are not a healthcare professional, select NO to exit.